OPTIMIZING
CONTACT
WITH WOUNDS.
Purified, micronized native porcine collagen.
Download the Brochure

COMPLEX SURGICAL WOUNDS.
COMPLEX PROBLEM.

Complex surgical wounds are generally left open to heal and must rely 
on the formation of new tissue (secondary intention healing).1

Healing is complicated by2:

Wound 
depth
Shape 
irregularity
Loss of 
subcutaneous tissue

Conventional, simple dressings are generally ineffective2 and thus a range of wounds may require more supportive healing measures post-operating room:

Venous leg ulcers
Diabetic foot ulcers
Open fractures
Limb salvage
Amputations
Surgical dehiscence
Pressure injuries
Fasciotomies
Mohs surgical defects
Tunneling wounds
Chronic wounds
Pressure ulcers
Trauma
Soft tissue

NATIVE COLLAGEN MATRIX.  
SUPPORTS A HEALING ENVIRONMENT.

PuraPly MZ leverages the PuraPly technology and contains purified, micronized native porcine collagen.3

With its proprietary process, PuraPly MZ maintains the native collagen structure.4

Collagen has been shown to help support a wound healing environment.4,5

PuraPly MZ Vial

MAXIMIZING COVERAGE FOR DEEP/TUNNELING WOUNDS.

With micronized, native collagen, PuraPly MZ enables 
access to difficult wound locations and maximizes:

Contact
Conformity
Coverage

HIGHLY ABSORPTIVE DRY POWDER. EASY TO USE.

Particle size ≤1000 μm3

Sterile device in a vial; sealed in a single pouch3

Can be applied dry or mixed with sterile solution to form a malleable paste3

Product NumberDescriptionTotal Size (mg)
515-059PURAPLYAM MZ100
515-061PURAPLYAM MZ500
515-063PURAPLYAM MZ1000

PORTFOLIO SOLUTION 
FOR COMPLEX SURGICAL WOUNDS.

PuraPly MZ can be used adjunctly with PuraPly AM.

PuraPly AM, as an antimicrobial barrier, helps control bioburden.6-9

PuraPly MZ, with the same native collagen structure, continues to support a healing environment.4


References:

  1. Hall J, et al. Wound Repair Regen. 2014;22(6):694-700.
  2. Ferreira MC, et al. Clinics (Sao Paulo). 2006;61(6):571-578.
  3. PuraPly Micronized [package insert]. Canton, MA: Organogenesis Inc; 2022.
  4. Data on file. PMZ_DR-0001. Organogenesis Inc.
  5. Araujo J, et al. Biomat App. 2020;0(0):1-18.
  6. PuraPly Antimicrobial [package insert]. Canton, MA: Organogenesis Inc; 2020.
  7. Hübner NO, et al. Skin Pharmacol Physiol. 2010;23(1 suppl):17-27.
  8. Davis SC, et al. Int Wound J. 2022;19(1):86-99.
  9. Brantley J, et al. Wounds Int. 2016;7(3):1-5.

WANT TO OPTIMIZE
CONTACT WITH
SURGICAL WOUNDS?
CONTACT US.

All fields required unless marked optional

We're sorry, it looks like something isn't right. Please see below.

THANK YOU

Your information has been received.